clinical trials for retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity This weight-loss drug hasn't been
Description
Qiu Q, Cao J, Wang Y, Zhang Y, Wei Y, Hao X, et al

Diabetes is an established risk factor for cardiovascular events such as stroke that is evaluated in cardiovascular outcome trials, with non-fatal stroke representing one of the three components of major adverse cardiovascular events (MACE)
Biondi, B., Kahaly, G

Skov J, Dejgaard A, Frkir J, et al

How GLP-1 Transformed This Patients Life: Laura struggled with low energy and her relationship with food, but with The GLP-1 treatment, she gained confidence, increased energy, and a healthier outlook on life

doi: 10.1056/NEJMoa1612917 16 GreenJBHernandezAFDAgostinoRBGrangerCBJanmohamedSJonesNPet al
